B-Group-Tech

/B-Group-Tech

About B-Group-Tech

This author has not yet filled in any details.
So far B-Group-Tech has created 4 blog entries.
16 04, 2018

Israel Medical Cannabis CANNAAN conference

2018-04-23T10:25:49+00:00

Bazelet will participate in the coming Israel Medical Cannabis CANNAAN conference, and will present 8 scientific contributions in the fields of:

  • ACCURATE REPRODUCIBLE TAILOR-MADE MEDICAL CANNABIS PRODUCTS – CHALLENGES AND SOLUTIONS (Oran presentation)
  • RE-THINKING MANUFACTURING AND R&D IN MEDICAL CANNABIS FIRM OF THE FUTURE (Poster)
  • TERPENE-BASED ENTOURAGE EFFECT HAS A GREAT POTENTIAL FOR IMPROVING MEDICAL CANNABIS THERAPEUTIC EFFECT (Poster)
  • CHALLENGES AND NEW DEVELOPMENTS IN CANNABIS EXTRACTION (Poster)
  • CANNABIS VETERINARY PRODUCT; IMPROVING HONEYBEES’ WELL BEING AND HONEY PRODUCTION (Poster)
  • MEDICAL CANNABIS FOR TREATING NEUROLOGICAL CONDITIONS (Poster)
  • THE CANNABIS TOOLBOX – THERAPEUTIC METHODOLOGIES AND CLINICAL GUIDANCE FOR MEDICAL PERSONNEL; ON THE WAY TO EBM (Poster)
  • TRAINING NEW CANNABIS PATIENTS AS A KEY TO SUCCESS AND CONTINUITY OF TREATMENT (Poster)
Israel Medical Cannabis CANNAAN conference 2018-04-23T10:25:49+00:00
22 02, 2018

Cannabis and Neurology

2018-03-26T12:51:31+00:00

Bazelet’s scientific paper dealing with medical cannabis treatment in various neurological conditions was published in the Neurology journal, the official journal of the Israel Neurological association (link to article in Hebrew)

Download in Hebrew
Cannabis and Neurology 2018-03-26T12:51:31+00:00
25 01, 2018

Bazelet’s new international patent application

2018-03-29T14:51:38+00:00

Bazelet’s new international patent application (WO2018015886) CANNABIS PRODUCTS AND INDUSTRIAL METHODS FOR PRODUCTION THEREOF is available online.

Abstract: Cannabis products and industrial methods for production thereof. A homogeneous composition comprising cannabinoid-containing comminuted cannabis plant material, where at least 70% weight of the comminuted cannabis plant material is of a size greater than 0.3 millimeter and less than 4.2 millimeters; the composition comprises at least 1% by weight moisture and less than 20% by weight moisture; and the cannabinoid concentration in a 1 gram fraction of at least 10 gram sample of said homogeneous composition, is within 15% of the cannabinoid concentration in a separate 1 gram fraction of said 10 gram sample

Bazelet’s new international patent application 2018-03-29T14:51:38+00:00
26 10, 2017

Bazelet’s new international patent application

2018-03-07T12:25:31+00:00

Bazelet’s new international patent application (WO2017182950) CANNABIS-ENRICHED ENZYMATICALLY TREATED THERAPEUTIC COMPOSITION is available online.

 Abstract: A cannabis-enriched enzymatically treated therapeutic composition. A therapeutic composition is described including water, glucose, glucose reaction product other than sucrose and fructose; a selected amount of a cannabinoid, a cannabinoid reaction product; optionally a terpene and optionally a terpene reaction product. Methods of making and using the compositions are also described.

Bazelet’s new international patent application 2018-03-07T12:25:31+00:00